Searched for
DOMESTIC BUSINESS PERFORMANCE
Mahindra clocks all-time high SUV sales of 73,338 units in October on festive demandMahindra & Mahindra reported its highest ever monthly SUV sales in October 2026 with significant increases. Domestic utility vehicle sales ...01 Nov, 2026, 12.18 PM IST- Corporate offsites, incentive trips make a comeback as companies resume travel plansCorporate offsites and incentive trips are witnessing a revival as companies resume travel plans. Businesses are now scheduling deferred tr...01 Nov, 2026, 08.05 AM IST
- Global business school applications fall 10%; Indian students increasingly turn to Europe, Asia: GMAC reportGlobal applications for graduate management education programmes declined by 10% for the 2026-27 class. Europe and Asia reported growth, wh...31 Oct, 2026, 03.25 PM IST
- Oil-to-chemicals business powers Reliance Industries' record quarterly net profit, up 34% to ₹29,550 croreReliance Industries Ltd has set a new benchmark with a record net profit of ₹29,550 crore for the September quarter, fueled by significant ...31 Oct, 2026, 09.38 AM IST
- Sun Pharma Q2 profit takes a hit on exceptional itemsSun Pharmaceutical has seen a notable 36% drop in net profit, juxtaposed with an 11.8% rise in consolidated revenue. The uplift in revenue ...31 Oct, 2026, 09.31 AM IST
- Sun Pharma Q2 profit falls 36% as litigation costs hit earningsSun Pharma reported a 36% decline in Q2FY27 net profit to Rs 1,989 crore due to exceptional litigation and acquisition-related costs. Reven...30 Oct, 2026, 10.14 PM IST
- Bank of Baroda Q2 Results: Standalone profit jumps 36% YoY to Rs 6,532 crore; NII up 9%Bank of Baroda reported a 35.8% year-on-year rise in standalone net profit to Rs 6,532 crore in Q2FY27. Net interest income grew 9% to Rs 1...30 Oct, 2026, 06.46 PM IST
- Sun Pharma Q2 Results: Profit falls 36% YoY to Rs 1,989 crore on exceptional chargesSun Pharma Q2 Results: Revenue from operations rose 12% YoY to Rs 16,199 crore from Rs 14,478 crore in Q2 of last financial year, supported...30 Oct, 2026, 03.38 PM IST
- Diwali blues: 83 largecap stocks plunge up to 60% since Samvat 2082. Can bluechips light up D-Street in the new year?Indian equities enter Samvat 2083 after a volatile year and a sharp market correction. While lower valuations have improved the risk-reward...30 Oct, 2026, 09.46 AM IST
- Adani Ports reports 18% net profit rise to Rs 3,682 crore in Q2 FY27Adani Ports and Special Economic Zone showcased a remarkable 18% increase in consolidated net profit for the September quarter. With a year...29 Oct, 2026, 08.44 AM IST
- Cipla’s US recovery, biosimilar pipeline key to future growth prospectsCipla's September-quarter earnings suffered due to a high base in its US business. The company reported sequential growth driven by its str...28 Oct, 2026, 05.56 AM IST
- Bajaj Auto Q2 Results: Profit jumps 35% YoY to Rs 3,354 crore; revenue up 34%Bajaj Auto Q2 Results: Revenue grew 34% YoY to Rs 20,003 crore for the first time, doubling over the past three years. The company also rep...27 Oct, 2026, 04.57 PM IST
- Cipla Q2 net profit falls 35% to Rs 878 crore, revenue dips 2%Cipla reported a 35% year-on-year decline in second-quarter net profit to Rs 878 crore, with revenue and EBITDA also falling amid weaker No...27 Oct, 2026, 03.41 PM IST
- Cipla expects US business to draw support from upcoming product pipelineCipla reported a significant decline in its consolidated net profit for the second quarter of FY27. The company's North American revenue fe...27 Oct, 2026, 03.09 PM IST
- Mankind Pharma shares jump 8% as Q2 profit rises 38% to Rs 716 croreMankind Pharma shares jumped nearly 8% after the company reported a 38% year-on-year rise in Q2 profit to Rs 716 crore. Revenue grew 17%, s...27 Oct, 2026, 12.55 PM IST
- Mankind Pharma Q2 profit rises 38% to Rs 716 croreMankind Pharma has announced a profit increase of 37.7% to ₹716 crore during the September quarter. Revenue from operations rose to ₹4,337....27 Oct, 2026, 07.30 AM IST
- Dr Reddy's bets on generic semaglutide, biosimilarsDr Reddy's domestic formulations business grew in the September quarter, while Revlimid sales declined in North America. A relaunch of gene...26 Oct, 2026, 01.19 AM IST
Load More
